Growth regulation and related applications of opioid antagonists

Details Growth regulation and related applications of opioid antagonists Growth regulation and related applications of opioid antagonists

1991-08-06

1993-11-30

Stoll, Robert L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514812, A61K 3141

Patent

active

052665747

ABSTRACT:
A method for regulating the growth processes in a myriad of cells, tissues, organ systems and unicellular and multicellular organisms including plants, animals and man by the administration of effective amounts of the opioid antagonists naloxone, naltrexone, their analogs, metabolites derivatives, and/or mixtures thereof. At the cellular level, the growth processes entail all mitotic events and related processes including cell proliferation, as well as cell migration and cell differentiation, and at the somatic or organismal level, anatomical, behavioral and neurological development, metamorphisis and maturation. Growth regulation can be effected in vivo and/or in vitro.

REFERENCES:
patent: 4689332 (1987-08-01), McLaughlin et al.
Amir, Shimon et al. "Chronic Naltrexone Administration . . . in Rats", Neuropharmocology, 18(11), 905-907, 1979.

Affiliated with

Also associated with

Rating

Growth regulation and related applications of opioid antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Growth regulation and related applications of opioid antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Growth regulation and related applications of opioid antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2096505